Extrait

To demonstrate that vildagliptin leads to a favorable hypoglycemic profile compared to sitagliptin, after 8 weeks of treatment, each, when used in combination with insulin. The hypoglycemic profile will be defined as the area under the glucose-time profile obtained by a 5 day-continuous glucose monitoring where the glucose levels are lower than the hypoglycemia threshold of 70 mg/dL.

Critère d'inclusion

• type-2 diabetes mellitus with pre-existing cardiovascular disease

Liens

• ictrp
• euctr